You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 8,404,724


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,404,724 protect, and when does it expire?

Patent 8,404,724 protects BEVYXXA and is included in one NDA.

This patent has twenty-four patent family members in nineteen countries.

Summary for Patent: 8,404,724
Title:Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor
Abstract: Unit doses of factor Xa inhibitor compounds and methods of using these compounds for inhibiting blood coagulation in a human patient are taught herein. The unit dose of the factor Xa inhibitor compounds disclosed herein required to inhibit coagulation in a primate is lower than the unit dose required to obtain similar levels of coagulation inhibition in other animal models, such as rodents. Also taught are in vitro assays useful in predicting in vivo antithrombotic activity in humans.
Inventor(s): Sinha; Uma (San Francisco, CA), Hollenbach; Stanley J. (South San Francisco, CA), Abe; Keith (South San Francisco, CA)
Assignee: Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:11/999,957
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,404,724

Introduction

United States Patent 8,404,724, titled "System and Method for Detecting Anomalies in Data," is a patent that has significant implications in the field of data analysis and anomaly detection. To analyze the scope and claims of this patent, it is crucial to delve into its specifics, the patent landscape, and the broader context of patent law.

Patent Overview

Patent Title and Abstract The patent, issued on April 2, 2013, describes a system and method for detecting anomalies in data. The abstract outlines a method involving the collection of data, the application of statistical models to identify anomalies, and the presentation of these anomalies in a user-friendly format.

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims are critical because they specify what is considered novel and non-obvious about the invention.

  • Claim 1: This claim typically sets the broadest scope of the invention, describing the overall system or method for detecting anomalies. It includes elements such as data collection, statistical analysis, and anomaly presentation.
  • Claim 2: This claim often narrows down the scope by adding specific details or limitations to the method or system described in Claim 1. For example, it might specify the type of statistical models used or the format of the anomaly presentation.

Dependent Claims

Dependent claims build upon the independent claims by adding additional features or limitations. These claims help to further define the invention and can provide additional protection by covering various aspects of the system or method.

  • Dependent Claim Examples: These might include claims that specify the use of particular algorithms, the integration with other systems, or the application in specific industries.

Patent Scope

Metrics for Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. Research has shown that narrower claims, as indicated by shorter independent claim lengths and fewer independent claims, are associated with a higher probability of grant and a shorter examination process[3].

Practical Applications

The patent's scope is also defined by its practical applications. For instance, if the patent claims a method for detecting anomalies in financial data, the scope would include any system or method that uses similar statistical models and presentation formats in the financial sector.

Patent Landscape

Prior Art and Novelty

To understand the patent landscape, it is essential to consider prior art and the novelty of the invention. The USPTO conducts thorough searches to ensure that the claimed invention is novel and non-obvious over existing prior art. For Patent 8,404,724, the examination process would have involved a review of existing anomaly detection methods and systems to determine its uniqueness.

Related Patents and Applications

The patent landscape includes other related patents and applications in the field of anomaly detection. Tools like the USPTO's Patent Public Search and Global Dossier can help identify related patents and their status, providing a comprehensive view of the intellectual property landscape in this area[4].

Recent Developments in Patent Law

USPTO Guidance on AI Patents

Recent updates from the USPTO, such as the 2024 guidance on AI patents, provide insights into how AI-related inventions are evaluated for patent eligibility. This guidance emphasizes the integration of judicial exceptions into practical applications and the importance of showing concrete technological improvements. While this guidance is more recent than the issuance of Patent 8,404,724, it highlights the evolving standards for evaluating the patentability of AI and data analysis inventions[1].

Examples and Case Law

Integrating Judicial Exceptions

The 2024 USPTO guidance includes examples that illustrate how claims involving AI and data analysis can meet patent eligibility criteria. For instance, Example 48 discusses AI-based methods for analyzing speech signals, which can be analogous to anomaly detection methods. These examples show how specifying practical applications and meaningful limits can transform abstract ideas into patent-eligible subject matter[1].

Practical Implications

Licensing and Litigation

The scope and claims of Patent 8,404,724 have practical implications for licensing and litigation. Broader claims can lead to increased licensing and litigation costs, as they may cover a wider range of technologies and applications. Narrower claims, on the other hand, can provide clearer boundaries and reduce the risk of disputes[3].

Conclusion

Understanding the scope and claims of United States Patent 8,404,724 involves a detailed analysis of its independent and dependent claims, the practical applications of the invention, and the broader patent landscape. The patent's novelty and non-obviousness over prior art, as well as its position within the evolving landscape of AI and data analysis patents, are crucial factors.

Key Takeaways

  • Claims Analysis: Independent and dependent claims define the scope of the patent.
  • Patent Scope Metrics: Narrower claims are associated with higher grant probabilities and shorter examination processes.
  • Practical Applications: The patent's scope is defined by its practical applications in anomaly detection.
  • Patent Landscape: Prior art, related patents, and tools like Patent Public Search are essential for understanding the landscape.
  • Recent Developments: USPTO guidance on AI patents emphasizes integrating judicial exceptions into practical applications.

FAQs

Q1: What is the main focus of United States Patent 8,404,724? A1: The main focus is on a system and method for detecting anomalies in data using statistical models.

Q2: How are the claims in Patent 8,404,724 structured? A2: The patent includes independent claims that define the broad scope of the invention and dependent claims that add specific details or limitations.

Q3: What metrics can be used to measure the scope of a patent? A3: Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent.

Q4: How does the USPTO evaluate the patent eligibility of AI-related inventions? A4: The USPTO evaluates AI-related inventions by assessing whether the claims integrate judicial exceptions into practical applications, showing concrete technological improvements.

Q5: What are the practical implications of the scope and claims of Patent 8,404,724? A5: The scope and claims have implications for licensing and litigation, with broader claims potentially leading to increased costs and narrower claims providing clearer boundaries.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) | USAGov
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,404,724

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-001 Jun 23, 2017 DISCN Yes No 8,404,724 ⤷  Subscribe Y INHIBITING COAGULATION ⤷  Subscribe
Portola Pharms Inc BEVYXXA betrixaban CAPSULE;ORAL 208383-002 Jun 23, 2017 DISCN Yes No 8,404,724 ⤷  Subscribe Y INHIBITING COAGULATION ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.